Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Highly effective and yet non-harmful: Fumaric acid esters to fight MS

26.03.2013
Firewall for nerve cells: RUBIN covers research reports
Success made in Bochum: Treatment of relapsing-remitting multiple sclerosis

Multiple sclerosis (MS) is a disease for which no cure has yet been found. Its progression may be delayed thanks to new drugs, but the active ingredients in those drugs are either only partially effective or may lead to severe side effects.

Recent developments in the field of dermatology have given rise to hope. Researchers in Bochum have discovered that MS symptoms are considerably alleviated through the application of an active pharmaceutical ingredient on the basis of fumaric acid that has long been successfully used against psoriasis.

Patients suffered 50% fewer flare-ups and the number of active inflammatory foci was reduced by up to 90%. Researchers have now discovered in what way fumaric acid esters protect nerve cells. Their report has been published in the international edition of RUBIN, the science magazine issued by the Ruhr University Bochum.

RUBIN online

The complete article with downloadable images may be found online at
http://www.ruhr-uni-bochum.de/rubin/rubin-international-2013/beitraege/beitrag1.html

MS: Most common neurological cause of disabilities in young adults.

Multiple sclerosis is the most common neurological cause of disabilities in young adults. In Germany, it currently affects some 130,000 patients. In MS patients, the body’s own immune system attacks the nerve fibres’ “insulating layer” and destroys it. Typically, all regions of the brain and the spinal cord are affected as the disease progresses. The inflammations result in ataxia, impairment of fine motor skills, as well as concentration loss, bladder function impairment, fatigue and depressive episodes.

Fruit acid approved for use in the food industry

Since the 1990s, various drugs that delay the progression of the disease by altering the immune system have been available. They are not harmful, yet their efficacy is quite limited. Particularly serious cases are treated with chemotherapeutic agent, which, however, may have severe, even life-threatening side effects. Researchers in Bochum have now discovered that an agent long known in the field of dermatology is highly effective in the treatment of MS episodes: fumaric acid ester. Fumaric acid is a fruit acid found in numerous plants and an approved food acidulant that also occurs naturally in the human body. The active agent has been successfully utilised in psoriasis therapy.

50% fewer episodes, 90% fewer inflammation foci

The discovery happened quite by accident: the MS symptoms of patients who suffered from both MS and psoriasis were alleviated following fumaric acid ester treatment. Accordingly, several studies were carried out. Prof Dr Ralf Gold’s team of neurologists have now presented the proof of fumaric acid ester’s efficacy: it triggers protective metabolic pathways in cells. “Nerve cells are thus protected, as if by a firewall, from inflammatory agents, mainly from free radicals and nitrogen monoxide,” explains Prof Gold. A large-scale study with more than 2,400 patients revealed that fumaric acid esters reduce MS episode frequency by up to 50% and the number of inflammatory foci visible in MRI scans by up to 90%. By changing the drug formula, indigestion, a common side effect of fumaric acid ester occurring in some 400 patients treated by the dermatological drug has been considerably reduced to some 3% to 5%. “Highly efficient and yet non-harmful – a wholly new experience in MS therapy!” Prof Gold says happily.
Bibliographic record

Ralf Gold et al.: Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis. In: N Engl J Med 2012; 367:1098-1107, September 20, 2012, DOI: 10.1056/NEJMoa1114287

Further information

Prof Dr med Ralf Gold, Director at the Neurology Clinic of the Ruhr University Bochum at St. Josef-Hospital, phone 0234/509-2410, ralf.gold@rub.de

Editor: Meike Drießen

Dr. Josef König | idw
Further information:
http://www.ruhr-uni-bochum.de/rubin/rubin-international-2013/beitraege/beitrag1.html

More articles from Health and Medicine:

nachricht Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>